NRF2, a Superstar of Ferroptosis
Antioxidants · 08.09.2023 · 12 (9) · 1739
DOI: 10.3390/antiox12091739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 08.09.2023. Verfasst von Ruihan Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Die Arbeit wurde bisher 232-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovative Research Team of High-level Local Universities in Shanghai.
Abstract (Originalsprache)
Ferroptosis is an iron-dependent and lipid peroxidation-driven cell death cascade, occurring when there is an imbalance of redox homeostasis in the cell. Nuclear factor erythroid 2-related factor 2 (NFE2L2, also known as NRF2) is key for cellular antioxidant responses, which promotes downstream genes transcription by binding to their antioxidant response elements (AREs). Numerous studies suggest that NRF2 assumes an extremely important role in the regulation of ferroptosis, for its various functions in iron, lipid, and amino acid metabolism, and so on. Many pathological states are relevant to ferroptosis. Abnormal suppression of ferroptosis is found in many cases of cancer, promoting their progression and metastasis. While during tissue damages, ferroptosis is recurrently promoted, resulting in a large number of cell deaths and even dysfunctions of the corresponding organs. Therefore, targeting NRF2-related signaling pathways, to induce or inhibit ferroptosis, has become a great potential therapy for combating cancers, as well as preventing neurodegenerative and ischemic diseases. In this review, a brief overview of the research process of ferroptosis over the past decade will be presented. In particular, the mechanisms of ferroptosis and a focus on the regulation of ferroptosis by NRF2 will be discussed. Finally, the review will briefly list some clinical applications of targeting the NRF2 signaling pathway in the treatment of diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Förderung
- National Natural Science Foundation of China
- Innovative Research Team of High-level Local Universities in Shanghai
Zitieren
APA
Yan, R., Lin, B., Jin, W., Tang, L., Hu, S., & Cai, R. (2023). NRF2, a Superstar of Ferroptosis. Antioxidants, 12(9), 1739. https://doi.org/10.3390/antiox12091739
Vancouver
Yan R, Lin B, Jin W, Tang L, Hu S, Cai R. NRF2, a Superstar of Ferroptosis. Antioxidants. 2023;12(9):1739. doi:10.3390/antiox12091739
BibTeX
@article{Yan2023,
author = {Yan, Ruihan and Lin, Bingyi and Jin, Wenwei and Tang, Ling and Hu, Shuming and Cai, Rong},
title = {NRF2, a Superstar of Ferroptosis},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {9},
pages = {1739},
doi = {10.3390/antiox12091739}
}
EUVIMED